26 Jul 2007

UCB: First Half-Year 2007 Financial Results

Read More
16 Jul 2007

UCB announces The U.S. Launch of Neupro® (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease

Read More
16 Jul 2007

UCB APPOINTS DETLEF THIELGEN AS CHIEF FINANCIAL OFFICER

Read More
13 Jul 2007

UCB Announces Registration of Domination and Profit Transfer Agreement Allowing Full Integration of Schwarz Pharma

Read More
2 Jul 2007

Luc Missorten has decided to pursue new opportunities

Read More
26 Jun 2007

UCB and Biogen Idec's oral VLA-4 antagonist (CDP323) enters phase II development for Multiple Sclerosis

Read More
14 Jun 2007

CIMZIA(TM) Effective in Reducing Signs and Symptoms of Rheumatoid Arthritis

Read More
29 May 2007

FDA approves XYZAL(R) tablets for the treatment of seasonal and year round allergies, and chronic urticaria

Read More
22 May 2007

UCB Presents Long-Term CIMZIA(TM) Data in Crohn's Disease

Read More
26 Apr 2007

Statement of the Chief Executive Officer of UCB to the 2007 Annual General Shareholders Meeting

Read More
Subscribe to